Business
Final Results
Incanthera PLC announced its audited results for the year ended March 31, 2025, highlighting the launch of its Skin+CELL luxury skincare range on August 11, 2025, and the achievement of first revenues from the range in its initial weeks. The company completed an institutional fundraise of £508,000 in June 2025. The total group loss for the year before exceptional items was £1,997k, which included a charge for share-based compensation of £214k. Operating expenses excluding share-based compensation increased to £1,783k. The cash position at the end of the period was £80k. The company expects to sell the current stock of 100,000 units by March 31, 2026. Disclaimer*
About this update from Incanthera Plc
[{"type":"text","content":"\n\n\n30 September 2025\n \nIncanthera plc\n(\"Incanthera\" or the \"Company\")\n \nFINAL RESULTS FOR THE YEAR ENDED 31 MARCH 2025\n \nIncanthera plc (AQSE: INC), the specialist company focused on innovative technologies in dermatology and oncology is pleased to announce its audited results for the year ended 31 March 2025.\n \nIncanthera is dedicated to identifying and commercialising novel therapeutic and cosmetic applications that are based upon uniquely targeted delivery technologies.\n \nPost Balance Sheet Highlights:\n \n· Skin+CELL luxury skincare range launched 11 August 2025 via a dedicated Direct To Consumer (\"DTC\") website\nLink: www.skinandcell.com\n· DTC campaign launched across social media, building into digital and traditional media \n· Skin+CELL products available for purchase include face, body and hand, face serum and eye cream\n· Proof of concept achieved for Skin+CELL formulation technology, demonstrating protective effects of Skin + CELL against UV-induced damage in human skin cells\n \nFinancial Highlights:\n \n· First revenues of Skin+CELL achieved in first weeks of launch\n· Institutional fundraise of £508,000 June 2025\n· Tight cost controls through lean business model\n· Protection of valuable IP across global territories\n \n \nSimon Ward, Chief Executive Officer, commented:\n \n\"I am immensely proud of our Skin+CELL product range, now available to the world-wide market, and achieving sales, following the launch on 11 August via our dedicated DTC website:\nwww.skinandcell.com\n \nThere has been immediate positive feedback from users of our Skin+CELL products, extolling the beneficial impact on their skin tone and appearance and confirming that Skin+CELL will be an integral part of their skin and beauty regimen going forward.\n \n\"As the DTC campaign has developed, we have seen good engagement and conversion to sales, increasing in recent weeks. As this gathers further momentum over the next period, we anticipate sales volumes to increase accordingly, and our expectation is to sell the current stock of 100,000 units by 31 March 2026.\n \n\"We are also actively explori...